ARCHIVES

Benefit Seen In Novel Drug That Treats Gleevec Resistance

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

Cancer Society, With Level Budget, Cuts On More Money to Fund “Pay Ifs” In FY92

March 27, 1992

In Brief: Ethics Commission To Consider Staff Proposal For Compensation Program At Future Meeting

March 13, 1981

Adding Aresenic To Therapy Improves APL Survival

July 27, 2007

Conference Explores Hype And Hope In Communicating Science News

May 15, 1998

ACOR Opens Cancer-pain.org

March 2, 2001

Administration to Request 3.9% Increase for NIH; 1.3% Raise For NCI In FY97

March 8, 1996